Skip to content
healthcare.dev

IBANDRONATE SODIUM

NDC 69452-378, IBANDRONATE SODIUM, tablet, from Bionpharma Inc..

Product NDC
69452-378
Status
Listed
Labeler
Bionpharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078998
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69452-378 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBANDRONATE SODIUM150 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
69452-378-74694520378741 BLISTER PACK in 1 CARTON (69452-378-74) / 3 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6ca94cce-a2bb-421f-bd8f-6b14bc2bd985
  • NADAC price for package 69452037874

    GET /v1/drugs/nadac/69452037874

Use it

Look up 69452-378 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69452-378 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69452-378. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.